Skip to main content
OpenTrials
Completed

NCT Number: NCT00450554

Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac

The main objective of the study is to estimate the proportion of children, born between the 01/01/2002 and the 06/23/200, living around Dieppe (cantons Dieppe est, Dieppe Ouest and Offranville), vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (>= 4), before and after the third MenBvac vaccination.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vaccination

Age range

2 year–7 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UH-rouen

Rouen, Seine Maritime, 76000, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • children born between 01/01/2000 and 06/23/2005, living in Dieppe-Est, Dieppe-Ouest and Offranville, vaccinated twice by MenBVac
  • parental authority(ies)assent

Exclusion criteria

  • no parental authority(ies)assent
  • no blood sample during the third vaccination
  • impossibility of third vaccination

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Official study title

EVALUATION DE LA REPONSE IMMUNITAIRE CONTRE LA SOUCHE DE NEISSERIA MENINGITIDIS B:14,P1.7,16

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Mar 22, 2007
Registry last updated
Mar 27, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.